Documents

Second booster vaccination against COVID-19

As of November 2021, an initial COVID-19 booster vaccination is being offered to all persons over the age of 18. The booster ...

Advisory report | 18-02-2022

Long-term symptoms after COVID-19

Some COVID-19 patients will experience persistent symptoms. This is generally called long COVID or post-COVID syndrome. The ...

Advisory report | 14-02-2022

Mental impact of the COVID-19 pandemic: an initial exploration of scientific literature

The Health Council of the Netherlands has reviewed the latest scientific knowledge in the first year of the COVID-19 pandemic. ...

Advisory report | 14-02-2022

Relevance of exposome research for policy

Research into the relationship between the living environment and health often focuses on understanding the effects of a single ...

Advisory report | 09-02-2022

Guidance for recommending classifications and health based occupational exposure limits

Other | 21-12-2021

Population Screening Act: study into personalised colorectal cancer

Since 2014, the Netherlands has had a population screening programme for colorectal cancer in which people aged 55 to 75 years ...

Advisory report | 20-12-2021

Evaluating newborn blood spot screening: a framework and initial assessment

In the Netherlands, infants are tested for 25 serious but treatable conditions through newborn blood spot screening (NBS). Early ...

Advisory report | 14-12-2021

COVID-19 vaccination of children aged 5 to 11

The Health Council concludes, based on the currently evidence, that for children aged 5-11 years the health benefits of ...

Advisory report | 10-12-2021

Employee vaccination: rotavirus

In June 2021, the Health Council recommended that all children be vaccinated against rotavirus. Following that recommendation, ...

Advisory report | 07-12-2021

Comments on draft advisory report 1-tert-butoxypropan-2-ol

Other | 06-12-2021